Selective expansion of a monocyte subset expressing the CD11c dendritic cell marker in the Yaa model of systemic lupus erythematosus - PubMed (original) (raw)

Selective expansion of a monocyte subset expressing the CD11c dendritic cell marker in the Yaa model of systemic lupus erythematosus

Hirofumi Amano et al. Arthritis Rheum. 2005 Sep.

Free article

Abstract

Objective: Monocytosis is a unique cellular abnormality associated with the Yaa (Y-linked autoimmune acceleration) mutation. The present study was designed to define the cellular mechanism responsible for the development of monocytosis and to characterize the effect of the Yaa mutation on the development of monocyte subsets.

Methods: We produced bone marrow chimeras reconstituted with a mixture of Yaa and non-Yaa bone marrow cells bearing distinct Ly-17 alloantigens, and determined whether monocytes of Yaa origin became dominant. Moreover, we defined the 2 major inflammatory (Gr-1+,CD62 ligand [CD62L]+) and resident (Gr-1-,CD62L-) subsets of blood monocytes in aged BXSB Yaa male mice, as compared with BXSB male mice lacking the Yaa mutation.

Results: Analysis of the Ly17 allotype of blood monocytes in chimeric mice revealed that monocytes of both Yaa and non-Yaa origin were similarly involved in monocytosis. Significantly, the development of monocytosis paralleled a selective expansion of the resident monocyte subset compared with the inflammatory subset, and the former expressed CD11c, a marker of dendritic cells. Neither monocytosis nor the change in monocyte subpopulations, including CD11c expression, was observed in Yaa-bearing C57BL/6 mice, in which systemic lupus erythematosus (SLE) fails to develop.

Conclusion: Our results suggest that Yaa-associated monocytosis is not attributable to an intrinsic abnormality in the growth potential of monocyte lineage cells bearing the Yaa mutation and that the Yaa mutation could lead to the expansion of dendritic cells, thereby contributing to the accelerated development of SLE.

PubMed Disclaimer

Cited by

Cytokine-induced monocyte characteristics in SLE.
Zhang Z, Maurer K, Perin JC, Song L, Sullivan KE. Zhang Z, et al. J Biomed Biotechnol. 2010;2010:507475. doi: 10.1155/2010/507475. Epub 2010 Jun 24. J Biomed Biotechnol. 2010. PMID: 20625490 Free PMC article.
Triglyceride-Rich Lipoproteins Modulate the Distribution and Extravasation of Ly6C/Gr1(low) Monocytes.
Saja MF, Baudino L, Jackson WD, Cook HT, Malik TH, Fossati-Jimack L, Ruseva M, Pickering MC, Woollard KJ, Botto M. Saja MF, et al. Cell Rep. 2015 Sep 22;12(11):1802-15. doi: 10.1016/j.celrep.2015.08.020. Epub 2015 Sep 3. Cell Rep. 2015. PMID: 26344769 Free PMC article.
Cutting edge: Type I IFN drives emergency myelopoiesis and peripheral myeloid expansion during chronic TLR7 signaling.
Buechler MB, Teal TH, Elkon KB, Hamerman JA. Buechler MB, et al. J Immunol. 2013 Feb 1;190(3):886-91. doi: 10.4049/jimmunol.1202739. Epub 2013 Jan 9. J Immunol. 2013. PMID: 23303674 Free PMC article.
Anti-TLR7 Antibody Protects Against Lupus Nephritis in NZBWF1 Mice by Targeting B Cells and Patrolling Monocytes.
Murakami Y, Fukui R, Tanaka R, Motoi Y, Kanno A, Sato R, Yamaguchi K, Amano H, Furukawa Y, Suzuki H, Suzuki Y, Tamura N, Yamashita N, Miyake K. Murakami Y, et al. Front Immunol. 2021 Nov 11;12:777197. doi: 10.3389/fimmu.2021.777197. eCollection 2021. Front Immunol. 2021. PMID: 34868046 Free PMC article.
TRAF5 is a critical mediator of in vitro signals and in vivo functions of LMP1, the viral oncogenic mimic of CD40.
Kraus ZJ, Nakano H, Bishop GA. Kraus ZJ, et al. Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):17140-5. doi: 10.1073/pnas.0903786106. Epub 2009 Sep 17. Proc Natl Acad Sci U S A. 2009. PMID: 19805155 Free PMC article.

Selective expansion of a monocyte subset expressing the CD11c dendritic cell marker in the Yaa model of systemic lupus erythematosus - PubMed (original) (raw)